Johnson & Johnson Talc Lawsuit: The $8+ Billion Settlement Story

Early Lawsuits and the First Major Verdicts

The litigation over Johnson & Johnson talcum powder products stretches back to the mid-2000s, when a growing body of scientific research began linking regular genital talc use to ovarian cancer. The first major talcum powder trial against J&J took place in 2013, with plaintiff Deane Berg winning a symbolic verdict — the jury found J&J liable but awarded no damages. This verdict, however, opened the floodgates.

The litigation accelerated dramatically in 2016, when Missouri juries began returning enormous verdicts against J&J. In February 2016, a St. Louis jury awarded $72 million to the family of Jacqueline Fox, who died of ovarian cancer. Two more multi-million-dollar verdicts followed later that year. These early verdicts — despite J&J's appeals — established a template that would be repeated hundreds of times in state and federal courts across the country.

The $4.69 Billion Ingham Verdict (2018)

The single most dramatic moment in the J&J talc litigation came in July 2018, when a St. Louis jury returned a verdict of $4.69 billion in the consolidated Ingham v. Johnson & Johnson case, representing 22 women who alleged talc caused their ovarian cancer.^[6] The jury awarded $550 million in compensatory damages and $4.14 billion in punitive damages. It was, at the time, one of the largest jury awards in U.S. history.

J&J appealed the Ingham verdict, and the Missouri Court of Appeals later reduced the award to approximately $2.12 billion while upholding the finding of liability. The case illustrated both the powerful evidence against J&J and the company's determination to fight rather than settle early verdicts.

MDL 2738: The Federal Multidistrict Litigation

As the volume of federal talcum powder lawsuits swelled, the U.S. Judicial Panel on Multidistrict Litigation consolidated thousands of cases into MDL 2738, assigned to Judge Freda Wolfson in the U.S. District Court for the District of New Jersey.^[2] At its peak, MDL 2738 included over 38,000 individual cases, making it one of the largest mass tort MDLs in U.S. history.

The MDL process allowed for coordinated discovery — including the retrieval of J&J's internal documents — and facilitated the development of expert witness testimony on causation. The internal documents obtained through MDL discovery were among the most damaging revelations in the litigation: they showed that J&J scientists and executives had been aware of potential asbestos contamination and cancer risks in their talc products since at least the 1970s, yet continued to market Baby Powder as safe.

Judge Wolfson oversaw extensive Daubert proceedings examining the admissibility of scientific expert testimony on both sides, ultimately allowing plaintiff experts to testify that talc causes ovarian cancer — a ruling that was critical to the plaintiffs' cases.

LTL Management: Two Failed Bankruptcy Attempts

Facing mounting litigation exposure, Johnson & Johnson devised a controversial legal strategy known colloquially as the 'Texas Two-Step.' In October 2021, J&J created a new subsidiary called LTL Management LLC, transferred its talc liabilities to this entity, and then had LTL file for Chapter 11 bankruptcy — triggering an automatic stay of all talcum powder litigation nationwide.

The strategy was immediately challenged by plaintiffs' attorneys as an abuse of the bankruptcy system. The Third Circuit Court of Appeals agreed: in January 2023, the court dismissed LTL's first bankruptcy filing, ruling that LTL was not in genuine financial distress and therefore did not satisfy the threshold requirement for Chapter 11 relief.

Undeterred, J&J restructured LTL and filed for bankruptcy again in April 2023, this time with a pre-negotiated settlement proposal of approximately $8.9 billion. The Third Circuit dismissed this second attempt in July 2023 as well, ^[3] finding again that LTL lacked the requisite financial distress. The court's twin rejections of the bankruptcy strategy returned the litigation to the civil courts and to the MDL.

The Kenvue Spin-Off and Strategic Restructuring

In parallel with the bankruptcy attempts, Johnson & Johnson executed another major strategic move: spinning off its entire consumer health division — including the Baby Powder brand — into a new public company called Kenvue Inc.^[7] The Kenvue IPO in May 2023 raised approximately $3.8 billion, making it one of the largest healthcare IPOs in history. J&J retained a majority stake before distributing its remaining Kenvue shares to J&J shareholders in August 2023.

The Kenvue spin-off separated J&J's pharmaceutical and medical device businesses from the consumer brands — including the talc-related liabilities. However, J&J retained legal responsibility for the talc litigation under the terms of the transaction and has continued to pursue settlement through the court system.

The $8+ Billion Settlement Proposal

After the failure of both bankruptcy attempts, Johnson & Johnson returned to the negotiating table. In May 2023, J&J announced a proposed settlement of approximately $8.9 billion to be paid over 25 years to resolve all current and future talcum powder claims.^[4] The proposal required approval from 75% of claimants — a threshold J&J initially failed to meet.

Plaintiffs' attorneys and legal commentators raised concerns about the structure of the settlement, including the long payout period, the per-claimant amounts relative to trial verdicts, and questions about how future claimants — women who might be diagnosed with ovarian cancer years from now due to past talc use — would be treated.

Negotiations over the final settlement terms continued into 2025 and 2026, with J&J periodically revising its proposal upward. As of the date of this article, the exact final settlement figure and structure remain subject to court approval and claimant acceptance, but the litigation represents one of the largest product liability settlements in pharmaceutical history.

Key Events Timeline

The J&J talc litigation spans more than a decade of courtroom battles, scientific revelations, and corporate maneuvering:

• 2013: First major talcum powder trial — Deane Berg wins liability verdict with no damages.
• 2016: Missouri juries begin returning multi-million-dollar verdicts; Fox family awarded $72 million.
• 2018: Ingham v. J&J — $4.69 billion verdict for 22 plaintiffs in St. Louis.
• 2019: FDA independent testing finds asbestos in J&J Baby Powder samples; J&J issues voluntary recall of ~33,000 bottles.
• 2020: J&J discontinues talc-based Baby Powder in the United States and Canada, citing 'misinformation' and 'litigation-fueled' media scrutiny.
• 2021: J&J creates LTL Management and files first Texas Two-Step bankruptcy.
• 2023 Jan: Third Circuit dismisses first LTL bankruptcy.
• 2023 Apr: LTL files second bankruptcy with $8.9B settlement proposal.
• 2023 Jul: Third Circuit dismisses second LTL bankruptcy.
• 2023 Aug: J&J completes Kenvue spin-off; J&J discontinues talc Baby Powder globally.
• 2024: IARC reclassifies genital talc as Group 1 (definite) human carcinogen.
• 2026: Settlement negotiations ongoing; litigation returns to civil courts.

Frequently Asked Questions